HB 1199

84(R) - 2015
House Business & Industry
House Business & Industry

Vote Recommendation

  • Neutral
  • Neutral
  • Neutral
  • Neutral
  • Neutral


David Simpson


Charles Anderson
Dustin Burrows
Terry Canales
Giovanni Capriglione
Travis Clardy
Garnet F. Coleman
Byron Cook
Joe Deshotel
Harold Dutton Jr.
Joe Farias
Allen Fletcher
James Frank
Charlie Geren
Bobby Guerra
Ryan Guillen
Roland Gutierrez
Patricia Harless
Abel Herrero
Donna Howard
Dan Huberty
Bryan Hughes
Celia Israel
Eric Johnson
James Keffer
Ken King
Stephanie Klick
J.M. Lozano
Eddie Lucio III
Armando Martinez
Ruth Jones McClendon
Will Metcalf
Joe Moody
Poncho Nevarez
Rene Oliveira
Gilbert Pena
Larry Phillips
Four Price
John Raney
Debbie Riddle
Matt Rinaldi
Eddie Rodriguez
Ramon Romero Jr.
Scott Sanford
Matt Shaheen
Kenneth Sheets
Ron Simmons
John Smithee
Jonathan Stickland
Ed Thompson
Senfronia Thompson
Tony Tinderholt
Chris Turner
Gary VanDeaver
Jason Villalba
Hubert Vo
Armando Walle
James White
Molly White
Gene Wu

Bill Caption

Relating to producing, selling, distributing, or promoting certain synthetic substances as a violation of the Deceptive Trade Practices-Consumer Protection Act.

Fiscal Notes

The Office of the Attorney General indicated the costs associated with implementation of the bill could be absorbed with existing resources. 

Bill Analysis

HB 1199 would broaden the definition of "false, misleading, or deceptive acts or practices" under the Deceptive Trade Practices-Consumer Protection Act to include: the production, sale, distribution, or promotion of a synthetic substance that produces and is intended to produce an effect when consumed or ingested similar to, or in excess of, the effect of a controlled substance or controlled substance analogue, making a deceptive representation or designation about the synthetic substance or causing confusion or misunderstanding as to the effects the synthetic substance causes when consumed or ingested.

HB 1199 would only apply to a cause of action that accrues on or after the effective date of this bill. 

Vote Recommendation Notes

This is one of many bills this session attempting to deal with the problem of synthetic drugs. It is unclear whether this would be an effective measure to combat the problem, therefore we are neutral.